Ganglioside GM3 Participates in the Pathological Conditions of Insulin Resistance
Open accessThe DOI matches its Crossref record; 60 of the 62 references it cites were found in a registry or an index.
Abstract
Gangliosides are known as modulators of transmembrane signaling by regulating various receptor functions. We have found that insulin resistance induced by tumor necrosis factor-alpha (TNF-alpha) in 3T3-L1 adipocytes was accompanied by increased GM3 ganglioside expression caused by elevating GM3 synthase activity and its mRNA. We also demonstrated that TNF-alpha simultaneously produced insulin resistance by uncoupling insulin receptor activity toward insulin receptor substrate-1 (IRS-1) and suppressing insulin-sensitive glucose transport. Pharmacological depletion of GM3 in adipocytes by an inhibitor of glucosylceramide synthase prevented the TNF-alpha-induced defect in insulin-dependent tyrosine phosphorylation of IRS-1 and also counteracted the TNF-alpha-induced serine phosphorylation of IRS-1. Moreover, when the adipocytes were incubated with exogenous GM3, suppression of tyrosine phosphorylation of insulin receptor and IRS-1 and glucose uptake in response to insulin stimulation was observed, demonstrating that GM3 itself is able to mimic the effects of TNF on insulin signaling. We used the obese Zucker fa/fa rat and ob/ob mouse, which are known to overproduce TNF-alpha mRNA in adipose tissues, as typical models of insulin resistance. We found that the levels of GM3 synthase mRNA in adipose tissues of these animals were significantly higher than in their lean counterparts. Taken together, the increased synthesis of cellular GM3 by TNF may participate in the pathological conditions of insulin resistance in type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and elimination of GM3 affects insulin receptor action (405, 523 -524).”
From Biological roles of glycans (2017) · cites this paper as [523]
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Heid, C. A., Stevens, J., Livak, K. J., & Williams, P. M. (1996) · Genome Research · doi:10.1101/gr.6.10.986 · Cited by 6,174
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Protection from obesity-induced insulin resistance in mice lacking TNF-α function
Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997) · Nature · doi:10.1038/39335 · Cited by 2,234
Aguirre, V., Uchida, T., Yenush, L., Davis, R., & White, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.9047 · Cited by 1,487
Boyle, W. J., van der Geer, P., & Hunter, T. (1991) · Methods in Enzymology · doi:10.1016/0076-6879(91)01013-r · Cited by 1,434
Tumor Necrosis Factor α: A Key Component of the Obesity-Diabetes Link
Hotamisligil, G. S., & Spiegelman, B. M. (1994) · Diabetes · doi:10.2337/diab.43.11.1271 · Cited by 1,281
Tumor necrosis factor alpha inhibits signaling from the insulin receptor.
Hotamisligil, G. S., Murray, D. L., Choy, L. N., & Spiegelman, B. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4854 · Cited by 1,199
Insulin Resistance — Mechanisms, Syndromes, and Implications
Epstein, F. H., Moller, D. E., & Flier, J. S. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109263251307 · Cited by 801
Research works printed but not linked: 4
- Moller, 1992, N. Engl. J. Med., 325, 938
- Radin, 1993, Adv. Lipid Res., 26, 183
- Tanaka, 1994, 76, 374
- Engelman, 2000, Mol. Endocrinol., 14, 1557
Cited by
Items 101–200 of 357
Gangliosides as Regulators of Cell Membrane Organization and Functions
Sonnino, S., & Prinetti, A. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6741-1_12 · Cited by 70
Promrat, K., Longato, L., Wands, J. R., & de la Monte, S. M. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00815.x · Cited by 66
Insulin resistance: a connecting link between Alzheimer's disease and metabolic disorder
Kshirsagar, V., Thingore, C., & Juvekar, A. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-020-00622-2 · Cited by 66
“Indeed, GM3 synthesis was inhibited with a glucosylceramide synthase inhibitor, which improved TNF-α-induced insulin resistance (Sekimoto et al. 2012), and it also prevented phosphorylation of IRS-1 at the tyrosine residues (Tagami et al. 2002).”
BackgroundMembrane microdomains and insulin resistance
Inokuchi, J. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.10.012 · Cited by 70
“This was reflected by increases in cellular GM3 content, GM3 synthase activity and GM3 synthase mRNA content, indicating that TNFa upregulates GM3 synthesis at the transcriptional level in cultured adipocytes [1].”
BackgroundMethodInfluentialSelf-citationGlycosphingolipids and Insulin Resistance
Aerts, J. M. F. G., Boot, R. G., van Eijk, M., Groener, J. E. M., Bijl, N., Lombardo, E., Biétrix, F., Dekker, N., Groen, A. K., Ottenhoff, R., et al. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0650-1_7 · Cited by 68
Ilan, Y. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00095.2016 · Cited by 65
Yoshizumi, S., Suzuki, S., Hirai, M., Hinokio, Y., Yamada, T., Yamada, T., Tsunoda, U., Aburatani, H., Yamaguchi, K., Miyagi, T., et al. (2007) · Metabolism · doi:10.1016/j.metabol.2006.10.027 · Cited by 66
Langeveld, M., de Fost, M., Aerts, J., Sauerwein, H., & Hollak, C. (2008) · Blood Cells, Molecules & Diseases · doi:10.1016/j.bcmd.2007.09.002 · Cited by 68
“GM3 has been shown to induce insulin resistance in vitro and in mouse models 18,19 and inhibition of glycosphingolipid synthesis leads to normalization of insulin signaling 20 .”
Adipose Tissue and Ceramide Biosynthesis in the Pathogenesis of Obesity
Samad, F., Badeanlou, L., Shah, C., & Yang, G. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0650-1_5 · Cited by 70
Lipid Microdomains and Insulin Resistance: Is There a Connection?
Ikonen, E., & Vainio, S. (2005) · Science s STKE · doi:10.1126/stke.2682005pe3 · Cited by 64
Recent advances in the glycosylation of sphingosines and ceramides
Morales‐Serna, J. A., Boutureira, O., Díaz, Y., Matheu, M. I., & Castillón, S. (2007) · Carbohydrate Research · doi:10.1016/j.carres.2007.03.028 · Cited by 69
Wang, X.-Q., Sheu, S. L., Wilson, H., Seeger, M., Iordanov, H., Gatla, N., Whittington, A., Bach, D. Q., Lu, J.-Y., & Paller, A. S. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.532 · Cited by 61
“GM3, a sialylated membrane-based glycosphingolipid, and the enzyme that synthesizes it, GM3 synthase (GM3S; also called SAT-I/ ST3Gal-V), are increased in the kidneys, liver, adipose tissue and muscle of murine models of diabetes (Memon et al., 1999; Tagami et al., 2002; Zador et al., 1993).”
BackgroundInfluentialGanglioside GM3 as a gatekeeper of obesity‐associated insulin resistance: Evidence and mechanisms
Lipina, C., & Hundal, H. S. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.09.018 · Cited by 57
“In accord with this, pharmacological inhibition of GM3 synthesis has been shown to reduce serine phosphorylation of IRS1 in response to TNF-a treatment, concomitantwith improved insulin sensitivity [41].”
BackgroundInfluentialPlaying hide and seek: Tumor cells in control of MHC class I antigen presentation
Jongsma, M. L. M., Neefjes, J., & Spaapen, R. M. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.05.009 · Cited by 56
Castillo, R. I., Rojo, L. E., Henriquez-Henriquez, M., Silva, H., Maturana, A., Villar, M. J., Fuentes, M., & Gaspar, P. A. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00488 · Cited by 51
Sphingolipids in obesity and related complications
Li, P.-L. (2017) · Frontiers in bioscience · doi:10.2741/4474 · Cited by 60
“First, insulin resistance induced by TNFα in 3T3-L1 adipocytes has been associated with elevated the GM3 levels caused by increased GM3 synthase abundance and activity (106).”
BackgroundInfluentialChen, Y., Qin, J., & Chen, Z. W. (2008) · Journal of Lipid Research · doi:10.1194/jlr.d800031-jlr200 · Cited by 52
“hibited by GM3 gangliosides through direct interaction with the receptors localized in microvillus (7, 15, 16), sug-”
BackgroundThe adipokine/ceramide axis: Key aspects of insulin sensitization
Xia, J. Y., Morley, T. S., & Scherer, P. E. (2014) · Biochimie · doi:10.1016/j.biochi.2013.08.013 · Cited by 52
“Studies in 3T3-L1 adipocytes have shown that TNFa can also cause insulin resistance by increasing the sphingolipid ganglioside GM3, which can attenuate insulin signaling at the level of the insulin receptor [80].”
BackgroundImaging mass spectrometry enables molecular profiling of mouse and human pancreatic tissue
Prentice, B. M., Hart, N. J., Phillips, N., Haliyur, R., Judd, A. M., Armandala, R., Spraggins, J. M., Lowe, C. L., Boyd, K. L., Stein, R. W., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-4855-8 · Cited by 52
Homeostatic and pathogenic roles of GM3 ganglioside molecular species in TLR4 signaling in obesity
Kanoh, H., Nitta, T., Go, S., Inamori, K., Veillon, L. J., Nihei, W., Fujii, M., Kabayama, K., Shimoyama, A., Fukase, K., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019101732 · Cited by 61
Self-citationVeillon, L. J., Go, S., Matsuyama, W., Suzuki, A., Nagasaki, M., Yatomi, Y., & Inokuchi, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129645 · Cited by 55
“Further, we have shown that expression of ganglioside GM3, which is the simplest ganglioside species synthesized by GM3 synthase (GM3S; also called SAT-I/ST3Gal-5), is increased in metabolic diseases [6,12].”
BackgroundSelf-citationInokuchi, J. (2014) · Glycoconjugate Journal · doi:10.1007/s10719-013-9516-4 · Cited by 52
“D-PDMP proved able to counteract TNFα-induced increase of GM3 content in adipocytes and completely normalize the TNFα-induced defect in tyrosine phosphorylation of IRS-1 in response to insulin stimulation [8].”
BackgroundInfluentialSelf-citationWennekes, T., Lang, B., Leeman, M., van der Marel, G. A., Smits, E., Weber, M., van Wiltenburg, J., Wolberg, M., Aerts, J. M. F. G., & Overkleeft, H. S. (2008) · Organic Process Research & Development · doi:10.1021/op700295x · Cited by 55
Serlie, M. J., Meijer, A. J., Groener, J. E., Duran, M., Endert, E., Fliers, E., Aerts, J. M., & Sauerwein, H. P. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2347 · Cited by 49
Glycosphingolipids and Infection. Potential New Therapeutic Avenues
Aerts, J. M. F. G., Artola, M., van Eijk, M., Ferraz, M. J., & Boot, R. G. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00324 · Cited by 52
Yamamoto, N., Matsubara, T., Sobue, K., Tanida, M., Kasahara, R., Naruse, K., Taniura, H., Sato, T., & Suzuki, K. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07668.x · Cited by 48
“Recently, it was reported that increased synthesis of cellular GM3 may be involved in the pathological mechanism of insulin resistance in type 2 diabetes (Tagami et al. 2002; Langeveld and Aerts 2009; Inokuchi 2011).”
BackgroundSetshedi, M., Longato, L., Petersen, D. R., Ronis, M., Chen, W. C., Wands, J. R., & de la Monte, S. M. (2011) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01569.x · Cited by 48
“The studies demonstrated similar mean levels of TNF-α, IL-4, IL-6, and VEGF among the five study groups (Table 4; Figure 4).”
BackgroundInfluentialCirculating levels of ganglioside GM3 in metabolic syndrome: A pilot study
Sato, T., Nihei, Y., Nagafuku, M., Tagami, S., Chin, R., Kawamura, M., Miyazaki, S., Suzuki, M., Sugahara, S.-I., Takahashi, Y., et al. (2008) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2008.06.001 · Cited by 50
“GM3 is a ominant ganglioside in blood, and is known to egatively modulate insulin signal transduction in nsulin-responsive cells [3,4,8].”
BackgroundSelf-citationMoore, M. L., Michael, H., Zhou, W., Goleniewska, K., O’Neal, J. F., Higginbotham, J. N., & Peebles, R. S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2651 · Cited by 47
“TNF- increases GM3 synthase gene transcription and GM3 levels (8).”
BackgroundSphingolipids: the nexus between Gaucher disease and insulin resistance
Fuller, M. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-113 · Cited by 58
“The addition of GM3 to cultured 3T3-adipocytes was shown to suppress insulin stimulated tyrosine phosphorylation of the insulin receptor and its downstream substrate, resulting in impaired glucose uptake [93].”
BackgroundMasson, E., Wiernsperger, N. F., Lagarde, M., & Bawab, S. E. (2005) · Biochemical Journal · doi:10.1042/bj20041506 · Cited by 50
Uemura, S., Yoshida, S., Shishido, F., & Inokuchi, J. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-12-1219 · Cited by 49
“In addition, GM3 itself forms lipid microdomains (rafts) that, with cholesterol and sphingomyelin, function as platforms for effective signal transduction in the plasma membrane ( Simons and Toomre, 2000 ) and participate in the regulation of numerous cellular processes, such as proliferation, differentiation, and adh…”
BackgroundSelf-citationDam, D. H. M., Wang, X.-Q., Sheu, S. L., Vijay, M., Shipp, D. M., Miller, L., & Paller, A. S. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.09.028 · Cited by 47
“, 2002), and glucosylceramide synthase inhibitors (GCSIs), which deplete GM3, reverse tumor necrosis factor-α–induced suppression of IR substrate-1 activation in adipocytes (Aerts et al., 2007; Tagami et al., 2002).”
BackgroundInfluentialSonnino, S., Aureli, M., Loberto, N., Chigorno, V., & Prinetti, A. (2010) · FEBS Letters · doi:10.1016/j.febslet.2009.11.020 · Cited by 44
“In insulin-resistant adipocytes, GM3 synthase was upregulated and GM3 was consistently accumulated [17] in detergent-resistant membranes leading to the displacement of IR from a complex with caveolin-1 and reduced response to insulin in terms of GLUT4 mediated glucose uptake [24].”
BackgroundInsulin Resistance as a Membrane Microdomain Disorder
Inokuchi, J. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.1532 · Cited by 50
Self-citationGanglioside GM3 Is Antiangiogenic in Malignant Brain Cancer
Seyfried, T. N., & Mukherjee, P. (2010) · Journal of Oncology · doi:10.1155/2010/961243 · Cited by 46
Wentworth, J. M., Naselli, G., Ngui, K., Smyth, G. K., Liu, R., O’Brien, P. E., Bruce, C. R., Weir, J. M., Cinel, M. A., Meikle, P. J., et al. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.223 · Cited by 46
Park, J., Kwak, C., Ha, S., Kwon, K., Abekura, F., Cho, S.-H., Chang, Y., Lee, Y., Ha, K., Chung, T., et al. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26287 · Cited by 44
Conditional LoxP‐flanked glucosylceramide synthase allele controlling glycosphingolipid synthesis
Yamashita, T., Allende, M. L., Kalkofen, D. N., Werth, N., Sandhoff, K., & Proia, R. L. (2005) · genesis · doi:10.1002/gene.20167 · Cited by 41
“The ganglioside GM3 has been shown to be a negative regulator of insulin receptor signaling, and its overexpression may be related to insulin resistance in type 2 diabetes (Tagami et al., 2002; Yamashita et al., 2003).”
BackgroundThe Role of Skeletal Muscle Sphingolipids in the Development of Insulin Resistance
Straczkowski, M., & Kowalska, I. (2008) · The Review of Diabetic Studies · doi:10.1900/rds.2008.5.13 · Cited by 41
“Inhibitors of glucosylceramide synthase prevent the effects of TNFα on insulin signaling [68] and enhance tyrosine phosphorylation of insulin receptors [69].”
BackgroundIsolation and characterization of the promoter region of the human GM3 synthase gene
Kim, S.-W., Lee, S., Kim, K.-S., Kim, C., Choo, Y., & Lee, Y. (2002) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(02)00505-5 · Cited by 41
Physiopathological function of hematoside (GM3 ganglioside)
Inokuchi, J. (2011) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.87.179 · Cited by 43
Self-citationControl of homeostatic and pathogenic balance in adipose tissue by ganglioside GM3
Nagafuku, M., Sato, T., Sato, S., Shimizu, K., Taira, T., & Inokuchi, J. (2014) · Glycobiology · doi:10.1093/glycob/cwu112 · Cited by 42
Self-citationCeramide and Sphingosine 1-Phosphate in Liver Diseases.
Park, W., Song, J.-H., Kim, G., & Park, T. (2020) · PubMed Central · doi:10.14348/molcells.2020.0054 · Cited by 47
“The exact mechanism of how GCS inhibition affects the development of fatty liver and insulin resistance is unclear, but the reduced ganglioside GM3, which plays an important role in insulin resistance (Tagami et al., 2002; Yamashita et al., 2003), could increase insulin sensitivity.”
BackgroundTargeting Glucosylceramide Synthesis in the Treatment of Rare and Common Renal Disease
Shayman, J. A. (2018) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2018.01.007 · Cited by 42
Inhibition of Rab prenylation by statins induces cellular glycosphingolipid remodeling
Binnington, B., Nguyen, L., Kamani, M., Hossain, D., Marks, D. L., Budani, M., & Lingwood, C. A. (2016) · Glycobiology · doi:10.1093/glycob/cwv084 · Cited by 37
Homeostatic and pathogenic roles of the GM3 ganglioside
Inokuchi, J., Kanoh, H., Inamori, K., Nagafuku, M., Nitta, T., & Fukase, K. (2021) · FEBS Journal · doi:10.1111/febs.16076 · Cited by 41
Self-citationKim, S.-J., Chung, T., Choi, H.-J., Kwak, C.-H., Song, K., Suh, S., Kwon, K., Chang, Y., Park, Y., Chang, H. W., et al. (2012) · Biochemical Journal · doi:10.1042/bj20120189 · Cited by 38
Multicomponent Synthesis of Ugi-Type Ceramide Analogues and Neoglycolipids from Lipidic Isocyanides
Pérez‐Labrada, K., Brouard, I., Méndez, I., & Rivera, D. G. (2012) · The Journal of Organic Chemistry · doi:10.1021/jo300462m · Cited by 39
The structure of gangliosides hides a code for determining neuronal functions
Lunghi, G., Fazzari, M., Biase, E. D., Mauri, L., Chiricozzi, E., & Sonnino, S. (2021) · FEBS Open Bio · doi:10.1002/2211-5463.13197 · Cited by 33
The clinical potential of sphingolipid-based therapeutics
Fox, T. E., Finnegan, C. M., Blumenthal, R., & KESTER, M. A. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5543-z · Cited by 38
Chemokines bind to sulfatides as revealed by surface plasmon resonance
Sandhoff, R., Grieshaber, H., Djafarzadeh, R., Sijmonsma, T., Proudfoot, A. E. I., Handel, T. M., Wiegandt, H., Nelson, P. J., & Gröne, H. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2004.11.011 · Cited by 35
Defining lipid mediators of insulin resistance: controversies and challenges
Metcalfe, L. K., Smith, G. C., & Turner, N. A. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0023 · Cited by 41
Shayman, J. A. (2013) · Europe PMC (PubMed Central) · Cited by 39
Distinct selectivity of gangliosides required for CD4+ T and CD8+ T cell activation
Inokuchi, J., Nagafuku, M., Ohno, I., & Suzuki, A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.07.013 · Cited by 33
“In obesity status, GSLs in lipid rafts are increased by pro-inflammatory cytokines such as TNFα produced by macrophages [39].”
BackgroundSelf-citationThe Role of Oxidized Cholesterol in Diabetes-Induced Lysosomal Dysfunction in the Brain
Sims-Robinson, C., Bakeman, A., Rosko, A., Glasser, R., & Feldman, E. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9207-1 · Cited by 31
“glucosamine residue, thereby playing a role in the regulation of insulin sensitivity [7, 8].”
Modulation of cell functions by glycosphingolipid metabolic remodeling in the plasma membrane
Prinetti, A., Chigorno, V., Mauri, L., Loberto, N., & Sonnino, S. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04714.x · Cited by 37
“1994)], and by insulin receptor [inhibited by GM3 but not by GD1a (Tagami et al. 2002)].”
BackgroundUemura, S. (2002) · Glycobiology · doi:10.1093/glycob/cwg022 · Cited by 33
“insulin receptor (Nojiri et al., 1991; Tagami et al., 2002 ).”
BackgroundSelf-citationMice lacking sialyltransferase ST3Gal-II develop late-onset obesity and insulin resistance
Lopez, P. H., Aja, S. M., Aoki, K., Seldin, M. M., Lei, X., Ronnett, G. V., Wong, G. W., & Schnaar, R. L. (2016) · Glycobiology · doi:10.1093/glycob/cww098 · Cited by 36
Liu, H., Ma, L., Lin, J., Cao, B., Qu, D., Luo, C., Huang, W., Han, L., Xu, H., Wu, Z., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104738 · Cited by 32
Sphingolipid Profiling: A Promising Tool for Stratifying the Metabolic Syndrome-Associated Risk
Berkowitz, L., Cabrera-Reyes, F., Salazar, C., Ryff, C. D., Coe, C. L., & Rigotti, A. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.785124 · Cited by 36
“For example, studies showed that GM3, a complex ganglioside, reduced insulin receptor presentation on the cell surface of adipocytes by modifying the composition of lipid rafts (77).”
Therapeutic Strategies for Diabetes and Complications: A Role for Sphingolipids?
Fox, T. E., & KESTER, M. A. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6741-1_14 · Cited by 34
Yew, N. S., Zhao, H., Hong, E., Wu, I., Przybylska, M., Siegel, C., Shayman, J. A., ARBEENY, C. M., Kim, J. K., Jiang, C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011239 · Cited by 33
“However, whole body fat mass was significantly reduced in the Genz-112638 treated mice fed the HFD (Fig.”
BackgroundInfluentialWen, Y., Wang, H., MacLaren, R., Wu, J., Lü, H., & Cianflone, K. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21631 · Cited by 30
“TNFa, IL-1b, IL-6 and macrophage secreted factors, all of which are associated with obesity and insulin resistance in vivo [Bastard et al., 2006], have also been shown to directly cause insulin resistance in 3T3-L1 cells models [Tagami et al., 2002; Lagathu et al., 2003, 2006; Permana et al., 2006].”
BackgroundInsulin Resistance as a Membrane Microdomain Disorder
Inokuchi, J. (2007) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.127.579 · Cited by 35
Self-citationInhibition of hepatocellular carcinoma growth by blockade of glycosphingolipid synthesis
Jennemann, R., Federico, G., Mathow, D., Rabionet, M., Rampoldi, F., Popović, Z. V., Volz, M., Hielscher, T., Sandhoff, R., & Gröne, H. (2017) · Oncotarget · doi:10.18632/oncotarget.22648 · Cited by 32
“GSLs also participate in signaling events [39]; they concentrate in lipid domains [40] and modify receptor activity of insulin- [41-43], leptin- [44], and epidermal growth factor receptor (EGFR) [45-47].”
BackgroundGanglioside Metabolism and Its Inherited Diseases
Breiden, B., & Sandhoff, K. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8552-4_5 · Cited by 37
Masson, E., Troncy, L., Ruggiero-Lopez, D., Wiernsperger, N. F., Lagarde, M., & Bawab, S. E. (2005) · Diabetes · doi:10.2337/diabetes.54.1.220 · Cited by 35
“Thus, GM3 synthase activity and its mRNA have been shown to be increased in adipocytes treated with low concentrations of tumor necrosis factor- , and GM3 synthase mRNA levels were found to be increased in adipose tissues of Zucker fa/fa rats (34).”
BackgroundPAQRs: A Counteracting Force to Ceramides?
Holland, W. L., & Scherer, P. E. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.054817 · Cited by 31
“The generation of ceramide and glucosylceramide are critical for TNF -mediated insulin resistance (Grigsby and Dobrowsky, 2001; Tagami et al., 2002).”
BackgroundLipidomics of Human Blood Plasma by High-Resolution Shotgun Mass Spectrometry
Sales, S., Knittelfelder, O. L., & Shevchenko, A. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7057-5_16 · Cited by 29
Sekimoto, J., Kabayama, K., Gohara, K., & Inokuchi, J. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.12.019 · Cited by 30
“Murine 3T3-L1 preadipocytes were cultured, maintained, and differentiated, as described previously [12].”
BackgroundResultSelf-citationUemura, S., Shishido, F., Tani, M., Mochizuki, T., Abe, F., & Inokuchi, J. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m048637 · Cited by 30
Self-citationThe Transport, Assembly, and Function of Myelin Lipids
Taylor, C. M., Marta, C. B., Bansal, R., & Pfeiffer, S. E. (2004) · Elsevier eBooks · doi:10.1016/b978-012439510-7/50056-5 · Cited by 37
The twists and turns of sphingolipid pathway in glucose regulation
Deevska, G. M., & Nikolova‐Karakashian, M. (2010) · Biochimie · doi:10.1016/j.biochi.2010.05.016 · Cited by 34
“The levels of GM3 synthase mRNA in adipose tissue of obese Zucker fa/fa rat and ob/ob mouse are higher than in tissues from their lean counterparts [57].”
β-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model
Yaʼacov, A. B., Zigmond, E., Tayer-Shifman, O. E., Lalazar, G., Zangen, S. W., Shasha, D., Sklair‐Levy, M., Zolotarov, L., Shalev, Z., Kalman, R., et al. (2014) · Journal of Inflammation Research · doi:10.2147/jir.s50508 · Cited by 33
“29–31 In the present study, β -glycosphingolipid level elevation may have affected β -cell function, with only a minor influence on peripheral insulin resistance.”
Glycosphingolipide – Natur, Funktion und pharmakologische Modulierung
Wennekes, T., van den Berg, R. J. B. H. N., Boot, R. G., van der Marel, G. A., Overkleeft, H. S., & Aerts, J. M. F. G. (2009) · Angewandte Chemie · doi:10.1002/ange.200902620 · Cited by 30
Organization of gangliosides into membrane nanodomains
Sarmento, M. J., Ricardo, J. C., Amaro, M., & Šachl, R. (2020) · FEBS Letters · doi:10.1002/1873-3468.13871 · Cited by 30
N-Azidoacetylmannosamine-mediated chemical tagging of gangliosides
Bussink, A. P., van Swieten, P. F., der Vlugt, K. G., Scheij, S. S., van Eijk, M., Wennekes, T., van der MAREL, G. A., Boot, R. G., Aerts, J. M. F. G., & Overkleeft, H. S. (2007) · Journal of Lipid Research · doi:10.1194/jlr.c700006-jlr200 · Cited by 34
“Endogenous cell surface GM3 was visualized by flow cytometry using monoclonal anti-GM3 antibody (Seikagu, Tokyo, Japan) and FITCconjugated secondary antibodies according to the procedure described previously (20).”
MethodCyclin-dependent Kinase-5 Is a Key Molecule in Tumor Necrosis Factor-α-induced Insulin Resistance
Nohara, A., Okada, S., Ohshima, K., Pessin, J. E., & Mori, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.231431 · Cited by 32
Balram, A., Thapa, S., & Chatterjee, S. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315442 · Cited by 34
“Treatment of 3T3-L1 adipocytes with GM3 repressed phosphorylation of the insulin receptor, which led to the repression of the insulin receptor pathway [39].”
BackgroundInfluentialAndo, Y., Shinozawa, Y., Iijima, Y., Yu, B., Sone, M., Ooi, Y., Watanaka, Y., Chida, K., Hakuno, F., & Takahashi, S. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.624759 · Cited by 33
Organization and function of glycosphingolipids in membrane
Hakomori, S. (2005) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.81.189 · Cited by 33
AICAR inhibits ceramide biosynthesis in skeletal muscle
Erickson, K. A., Smith, M., Anthonymuthu, T. S., Evanson, M. J., Brassfield, E. S., Hodson, A. E., Bressler, M. A., Tucker, B. J., Thatcher, M. O., Prince, J. T., et al. (2012) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-4-45 · Cited by 35
“Similar to these glycerolipids, palmitate induced a robust increase in ceramides and glucosylceramides (Figure 1C and D, respectively), which have both been implicated in mediating lipidinduced insulin resistance [26,27].”
ResultLalazar, G., Zigmond, E., Weksler‐Zangen, S., Yaʼacov, A. B., Lévy, M., Hemed, N., Raz, I., & Ilan, Y. (2017) · Journal of Medicinal Food · doi:10.1089/jmf.2016.3753 · Cited by 29
“Glycosphingolipids were suggested to negatively modulate the activity of the insulin receptor, 34 the use of Genz-123346, an inhibitor of glycosphingolipid synthesis, was hypothesized to improve insulin sensitivity and glucose control.”
Ramos‐Molina, B., Rossell, J., de, A. P.-M., Pardina, E., Genua, I., Rojo-López, M. I., Julián, M. T., Alonso, N., Julve, J., & Mauricio, D. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1400961 · Cited by 32
“There are several possible mechanisms by which sphingolipids can modulate insulin signaling: a) ceramides are described to impair insulin activation of Akt/PKB altering its translocation (via PKC z or protein phosphatase 2 a -PP2A); b) alternatively-phosphorylated RNA-dependent protein kinase (PKR) by ceramides would…”
BackgroundSasaki, N., Itakura, Y., & Toyoda, M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.684274 · Cited by 32
“GSL Synthesis Inhibitor Restores the Defect of Insulin Signaling in Senescent ECs—So far it has been shown that increased abundances of GM1 and GM3 in the cell membrane contribute to insulin resistance (15, 24).”
BackgroundDifferential Gene Expression Profiling of Dystrophic Dog Muscle after MuStem Cell Transplantation
Robriquet, F., Lardenois, A., Babarit, C., Larcher, T., Dubreil, L., Leroux, I., Zuber, C., Ledevin, M., Deschamps, J., Fromes, Y., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123336 · Cited by 30
“Insulin resistance in adipocytes induced by TNFα is accompanied by an increased GM3 biosynthesis through the up-regulation of GM3 synthase (ST3GAL5) gene expression [72].”
BackgroundUemura, S., Go, S., Shishido, F., & Inokuchi, J. (2013) · Glycoconjugate Journal · doi:10.1007/s10719-013-9499-1 · Cited by 28
Self-citationCombined Ugi‐4CR/CuAAC Approach to Triazole‐Based Neoglycolipids
Pérez‐Labrada, K., Brouard, I., Méndez, I., Pérez, C., Gavín, J. A., & Rivera, D. G. (2014) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201402117 · Cited by 27
Role of Glycosphingolipids in Dendritic Cell-Mediated HIV-1 Trans-infection
Puryear, W. B., & Gummuluru, S. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4433-6_5 · Cited by 28
“Intriguingly, immune activation stimuli upregulate cell surface expression of GM3 in CD4+ T cells and macrophages (Blander et al. 1999; Nojiri et al. 1986; Tagami et al. 2002; Gracheva et al. 2007), and hence, enhanced incorporation of GM3 on HIV-1 particles derived from these cells (Puryear et al.”
BackgroundTsai, Y., Shih, C.-H., Su, Y.-T., Yao, C., Lian, J.-F., Liao, C. ‐., Hsia, C., Shui, H., & Rani, R. (2011) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob06827c · Cited by 26
Menichella, D. M., Jayaraj, N. D., Wilson, H. M., Ren, D., Flood, K. S., Wang, X.-Q., Shum, A. K., Miller, R. J., & Paller, A. S. (2016) · Molecular Pain · doi:10.1177/1744806916666284 · Cited by 26
“Increasing evidence suggests that GM3 accumulation is a mediator of Tumor Necrosis Factor (TNF)-induced insulin resistance.(13,16) We have recently shown that ganglioside GM3 plays a role in the impaired wound healing of diabetes, at least in part through its suppression of insulin/insulin-like growth factor-1 recepto…”
BackgroundLipidomic Evaluation of Feline Neurologic Disease after AAV Gene Therapy
Gray‐Edwards, H. L., Jiang, X., Randle, A. N., Taylor, A. R., Voss, T. L., Johnson, A. K., McCurdy, V. J., Sena‐Esteves, M., Ory, D. S., & Martin, D. R. (2017) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2017.07.005 · Cited by 26
“It functions in cell proliferation, differentiation, embryogenesis, apoptosis, oncogenesis, and insulin resistance.(14,15) Secondary increases of GM3 have been reported in several lysosomal storage disorders, including the mucopolysaccharidoses,(16) NiemannPick disease type C,(17) Gaucher disease,(18,19) and GM2 gangl…”
BackgroundNitta, T., Kanoh, H., Inamori, K., Suzuki, A., Takahashi, T., & Inokuchi, J. (2018) · Glycobiology · doi:10.1093/glycob/cwy105 · Cited by 26
Self-citationGangliosides Contribute to Vascular Insulin Resistance
Sasaki, N., Itakura, Y., & Toyoda, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081819 · Cited by 28
“7 ng/mL) of TNFα are known to upregulate GM3 [43].”
BackgroundGangliosides in Diabetic Wound Healing
Dam, D. H. M., & Paller, A. S. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.12.006 · Cited by 25
Role of hypothalamic de novo ceramides synthesis in obesity and associated metabolic disorders
Magnan, C., & Stunff, H. L. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101298 · Cited by 27
“However, the ganglioside sialosyllactosylceramide (GM3) suppresses activation of the insulin receptor signalling pathway that results in reduced glucose uptake in adipocytes [82].”
BackgroundShui, G., Lam, S. M., Stebbins, J. W., Kusunoki, J., Duan, X., Li, B., Cheong, W. F., Soon, D., Kelly, R. P., & Wenk, M. R. (2013) · Metabolomics · doi:10.1007/s11306-013-0494-0 · Cited by 26
Herzer, S., Meldner, S., Gröne, H., & Nordström, V. (2015) · Diabetes · doi:10.2337/db14-1726 · Cited by 28
“GM3 inhibits IR signaling (21) by sequestering IRs from caveolae (22).”
BackgroundStrekalova, T. V., Svirin, E. P., Veniaminova, E. A., Kopeikina, E., Veremeyko, T., Yung, A. W. Y., Proshin, A. T., Walitza, S., Anthony, D. C., Lim, L. W., et al. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100306 · Cited by 26
“Specifically, gangliosides have been shown to regulate the effects of tumour necrosis factor (TNF) (Tagami et al., 2002), microglial and platelet activation (Dukhinova et al., 2018; Sotnikov et al., 2013), nitric oxide synthase (NOS2), and ICAM-1 and MCP-1-mediated signalling (Kim et al., 2002; Ryu…”
Background
Metadata
- Authors
- Tagami, S., Inokuchi, J.-I., Kabayama, K., Yoshimura, H., Kitamura, F., Uemura, S., Ogawa, C., Ishii, A., Saito, M., Ohtsuka, Y., Sakaue, S., & Igarashi, Y.
- Affiliations
- Hokkaido University (JP)
- National Cancer Centre Japan (JP)
- Corresponding author
- Inokuchi, Jin-ichi
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-02
- Volume
- 277
- Issue
- 5
- Pages
- 3085-3092
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2157934599
- Cited by
- 355
- References
- 62
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 10 · 2023: 2 · 2022: 16 · 2021: 14 · 2020: 27 · 2019: 14 · 2018: 13 · 2017: 13 · 2016: 14 · 2015: 23 · 2014: 17 · 2013: 18 · 2012: 19
- FWCI
- 8.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6818 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- GM3 ganglioside, insulin resistance, TNF-α, GM3 synthase, IRS-1, IRS-1 serine phosphorylation, insulin receptor tyrosine phosphorylation, glucose transport, adipocytes, type 2 diabetes, obesity, glucosylceramide synthase inhibition, 3T3-L1 adipocytes, Zucker fatty rats, ob/ob mice
- MeSH terms
- Animals, Cell Differentiation, Enzyme Inhibitors, G(M3) Ganglioside, Glucosyltransferases, Insulin, Insulin Resistance, Mice, Obese, Rats, Zucker, Sialyltransferases, Transcription, Genetic, Tumor Necrosis Factor-alpha, Signal Transduction, 3T3 Cells, Adipocytes, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.